#PATHBOARDS High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors)
Dr. Jeremiah X. Karrs, DO, Assistant Professor of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center & Geisel School of Medicine at Dartmouth, discusses "High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors)" Explore pathCast on the new website: https://pathcast.net/ Follow #pathCast Facebook: / pathcast YouTube: / @pathcast
▶︎
#PATHBOARDS HIGH - YIELD MOLECULAR PATHOLOGY FOR BOARDS - PART 1 (SOLID TUMORS)
▶︎
#GIPATH Selected Updates from the WHO 6th Edition Classification of Digestive System Tumors
▶︎
#PATHBOARDS HIGH - YIELD GU PATHOLOGY FOR BOARDS
▶︎
#PBPATH Pancreatobiliary Neuroendocrine Neoplasms: Updates on the New WHO Tumor Classification
▶︎
Live Q&A with Brian Greene | World Science Festival
▶︎
Jfrog | Jfrog Artifactory | Jfrog Artifactory Tutorial | Artifactory Tutorial | Intellipaat
▶︎
#LIVERPATH Liver Tumor Classification in the 6th Edition of the WHO
▶︎
Beyond WHO 2022: A Pragmatic, Clinically Relevant Approach to Low-Risk Renal Oncocytic Neoplasms
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
#DIGITALPATH Agentic AI + Open Data: Democratizing Computational Pathology Research
▶︎
Ms. Rachel Answers Parenting Questions | Tech Support | WIRED
▶︎
The future of nuclear power: challenges and perspectives
▶︎
#DERMPATH Untangling Alopecia: Histopathology Patterns
▶︎
Britain's belated reckoning with the IRGC | feat. Robin Simcox
▶︎
#LIVERPATH Great Things Often Begin Small: Canals of Hering, Ductular Reactions and Stem Cells
▶︎
International Conference Highlights - ASCO 2026
▶︎
#DERMPATH Metastatic Tumors to Skin
▶︎
Big Pharma's Trillion Dollar Deception on Mental Health | Joanna Moncrief
▶︎
#PATHOLOGY Oncogenic Viruses: Mechanisms, Associated Cancers and Testing Methodologies
▶︎